Lymphopenia During Definitive Chemoradiotherapy in Esophageal Squamous Cell Carcinoma: Association with Dosimetric Parameters and Patient Outcomes.

MLA

Xu, Hui, et al. “Lymphopenia During Definitive Chemoradiotherapy in Esophageal Squamous Cell Carcinoma: Association with Dosimetric Parameters and Patient Outcomes.” Oncologist, vol. 26, no. 3, Mar. 2021, pp. e425–34. EBSCOhost, https://doi.org/10.1002/onco.13533.

APA

Xu, H., Lin, M., Hu, Y., Zhang, L., Li, Q., Zhu, J., Wang, S., & Xi, M. (2021). Lymphopenia During Definitive Chemoradiotherapy in Esophageal Squamous Cell Carcinoma: Association with Dosimetric Parameters and Patient Outcomes. Oncologist, 26(3), e425–e434. https://doi.org/10.1002/onco.13533

Chicago

Xu, Hui, Maosheng Lin, Yingying Hu, Li Zhang, Qiaoqiao Li, Jinhan Zhu, Shi Wang, and Mian Xi. 2021. “Lymphopenia During Definitive Chemoradiotherapy in Esophageal Squamous Cell Carcinoma: Association with Dosimetric Parameters and Patient Outcomes.” Oncologist 26 (3): e425–34. doi:10.1002/onco.13533.